COST-EFFECTIVENESS OF BOCEPREVIR THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C (HCV) GENOTYPE 1

被引：1
|
作者：
Mernagh, P. [1 ]
Feng, J. [1 ]
Del Cuore, M. [2 ]
机构：
[1] Optum, Sydney, NSW, Australia
[2] Merck Sharp & Dohme Australia, Sydney, NSW, Australia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.440
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A94 / A94
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness of Telaprevir in Patients with Genotype 1 Hepatitis C in Australia
    Warren, Emma
    Wright, Alison
    Jones, Brandon
    VALUE IN HEALTH, 2014, 17 (08) : 792 - 800
  • [22] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [23] Boceprevir targets chronic hepatitis C genotype 1
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (09) : 489 - 489
  • [24] THE COST-EFFECTIVENESS OF HEPATITIS C TREATMENTS IN TREATMENT NAIVE GENOTYPE 1 PATIENTS
    McGinnis, J. J.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A274 - A274
  • [25] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Jacobs, RJ
    Koff, RS
    HEPATOLOGY, 2000, 32 (04) : 873 - 874
  • [26] Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Myers, RP
    Gregor, JC
    Marotta, PJ
    GASTROENTEROLOGY, 1999, 116 (04) : A1252 - A1252
  • [27] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [28] The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
    Myers, RP
    Gregor, JC
    Marotta, PJ
    HEPATOLOGY, 2000, 31 (04) : 834 - 839
  • [29] Boceprevir for Chronic HCV Genotype 1 Infection
    Limaye, Alpna R.
    Draganov, Peter V.
    Cabrera, Roniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (02) : 176 - 176
  • [30] COST-EFFECTIVENESS OF HCV TREATMENT IN GENOTYPE 1 NAIVE PATIENTS IN 2012
    de Ledinghen, V.
    Orsini, M.
    Foucher, J.
    Vergniol, J.
    Chermak, F.
    Messaoudi, N.
    Daures, J. -P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S384 - S385
12345